Evolutia Bio
PrivateLast Round
Private Placement
Jul 18, 2024
Total Funding Raised
$31.89M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Evolutia Bio is a biotechnology company that develops proprietary biomanufacturing solutions, including custom enzymes, engineered strains, and processes for ingredient and industrial partners.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Smart Manufacturing, Sustainable Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evolutia Bio Comparables
Compare Evolutia Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Conagen | 85% | |
| Lygos | 82% | |
| Manus Bio | 81% |
Evolutia Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Jul 18, 2024 | ||||
| Convertible Debt | Oct 10, 2023 | ||||
| Follow-on Offering | Feb 19, 2021 | ||||
| Follow-on Offering | Oct 29, 2020 |
Evolutia Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canaccord Genuity | Follow-on Offering |
| ATB Capital Markets | Follow-on Offering |
| BMO Capital Markets | Follow-on Offering |
| Eight Capital | Follow-on Offering |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 23, 2026
Grew 19% QoQ, from 21 to 25 employees.
- Aug 21, 2026
Monthly visitors grew 39% MoM, reaching 2.5K.
Evolutia Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Evolutia Bio's valuation, stock price, and market status.
Is Evolutia Bio a public or private company?
Evolutia Bio is a private company.
What is the current stock price of Evolutia Bio?
Evolutia Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Evolutia Bio worth (valuation)?
Valuation information for Evolutia Bio is not publicly available.
Can I buy Evolutia Bio stock?
Evolutia Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Evolutia Bio's last funding round?
Funding round information for Evolutia Bio is not publicly available.
Who are the main investors in Evolutia Bio?
Investor information for Evolutia Bio is not publicly disclosed.
Will Evolutia Bio IPO soon?
No public IPO plans have been announced for Evolutia Bio.
How can I track Evolutia Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Evolutia Bio's secondary market activity and sign up for updates.